Company Search:
Advanced Search
Sponsored Links
Molecular Partners AG Company Snapshot
Molecular Partners AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Molecular Partners AG with three other miscellaneous service companies in Europe: Selvita SA of Poland (2017 sales of 67.54 million Polish New Zlotys [US$17.94 million] of which 65% was Services), Zealand Pharma A/S of Denmark (139.78 million Danish Kroner [US$21.31 million] of which 100% was Biopharmaceuticals), and Adocia SAS which is based in France (19.47 million Euro [US$22.15 million] of which 100% was Regenerative Medicine).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Molecular Partners AG
  Stock Performance Chart for Molecular Partners AG
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 17.76
(Figures in Swiss Francs)
1 Week 1.5%   13 Weeks -4.8%  
4 Weeks -10.0%   52 Weeks -29.7%  
Molecular Partners AG Key Data:
  Ticker: MOLN Country: Switzerland
  Exchanges: ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 20,016,000
(Year Ending Jan 2018).
Employees: 108
  Currency: Swiss Francs Market Cap: 376,171,683
  Fiscal Yr Ends: December Shares Outstanding: 21,180,838
  Share Type: Namenaktie Closely Held Shares: 8,597,079
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.